These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17951226)

  • 21. Assessment of symptom clusters in people with cancer.
    Paice JA
    J Natl Cancer Inst Monogr; 2004; (32):98-102. PubMed ID: 15263048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model.
    Bruner DW
    J Natl Cancer Inst Monogr; 2007; (37):12-5. PubMed ID: 17951225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom clusters: the new frontier in symptom management research.
    Miaskowski C; Dodd M; Lee K
    J Natl Cancer Inst Monogr; 2004; (32):17-21. PubMed ID: 15263036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.
    Wagner LI; Wenzel L; Shaw E; Cella D
    J Clin Oncol; 2007 Nov; 25(32):5058-62. PubMed ID: 17991921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of neutropenia on the impact of a cognitive-behavioral intervention for symptom management.
    Given BA; Given CW; Jeon S; Sikorskii A
    Cancer; 2005 Aug; 104(4):869-78. PubMed ID: 15971198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.
    Buchanan DR; O'Mara AM; Kelaghan JW; Sgambati M; McCaskill-Stevens W; Minasian L
    Cancer; 2007 Oct; 110(7):1621-8. PubMed ID: 17868120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in what quality-of-life instruments measure.
    Ferrans CE
    J Natl Cancer Inst Monogr; 2007; (37):22-6. PubMed ID: 17951227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.
    Capo' JP; Laramée C; Lucente V; Fakhoury A; Forero-Schwanhaeuser S
    Int J Clin Pract; 2008 Jan; 62(1):39-46. PubMed ID: 18036164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electronic patient-reported outcome systems in oncology clinical practice.
    Bennett AV; Jensen RE; Basch E
    CA Cancer J Clin; 2012; 62(5):337-47. PubMed ID: 22811342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes.
    Caocci G; La Nasa G; Efficace F
    Expert Rev Hematol; 2009 Feb; 2(1):69-80. PubMed ID: 21082996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing cancer-related quality of life across a spectrum of applications.
    Gotay CC
    J Natl Cancer Inst Monogr; 2004; (33):126-33. PubMed ID: 15504923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Cancer Care Monitor items for physical symptoms and treatment side effects using expert oncology nurse evaluation.
    Fortner B; Baldwin S; Schwartzberg L; Houts AC
    J Pain Symptom Manage; 2006 Mar; 31(3):207-14. PubMed ID: 16563315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
    J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life assessment in multiple sclerosis.
    Miller DM; Kinkel RP
    Rev Neurol Dis; 2008; 5(2):56-64. PubMed ID: 18660737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
    Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
    BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team.
    Delgado-Guay MO; Parsons HA; Li Z; Palmer LJ; Bruera E
    Cancer; 2009 Jan; 115(2):437-45. PubMed ID: 19107768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.